We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · April 16, 2021

Direct Oral Anticoagulants vs Warfarin in Patients With Valvular Atrial Fibrillation

Annals of Internal Medicine


Additional Info

Annals of Internal Medicine
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation: A Population-Based Cohort Study
Ann. Intern. Med 2021 Mar 30;[EPub Ahead of Print], GK Dawwas, E Dietrich, A Cuker, GD Barnes, CE Leonard, JD Lewis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading